Literature DB >> 14720123

TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.

Hwang-Phill Kim1, Mi-Sook Lee, Jiyon Yu, Jin-Ah Park, Hyun-Soon Jong, Tae-You Kim, Jung Weon Lee, Yung-Jue Bang.   

Abstract

Signalling by integrin-mediated cell anchorage to extracellular matrix proteins is co-operative with other receptor-mediated signalling pathways to regulate cell adhesion, spreading, proliferation, survival, migration, differentiation and gene expression. It was observed that an anchorage-independent gastric carcinoma cell line (SNU16) became adherent on TGF-beta1 (transforming growth factor beta1) treatment. To understand how a signal cross-talk between integrin and TGF-beta1 pathways forms the basis for TGF-beta1 effects, cell adhesion and signalling activities were studied using an adherent subline (SNU16Ad, an adherent variant cell line derived from SNU16) derived from the SNU16 cells. SNU16 and SNU16Ad cells, but not integrin alpha5-expressing SNU16 cells, showed an increase in adhesion on extracellular matrix proteins after TGF-beta1 treatment. This increase was shown to be mediated by an integrin alpha3 subunit, which was up-regulated in adherent SNU16Ad cells and in TGF-beta1-treated SNU16 cells, compared with the parental SNU16 cells. After TGF-beta1 treatment of SNU16Ad cells on fibronectin, Tyr-416 phosphorylation of c-Src was increased, but Ras-GTP loading and ERK1/ERK2 (extracellular-signal-regulated kinases 1 and 2) activity were decreased, which showed a dependence on c-Src family kinase activity. Studies on adhesion and signalling activities using pharmacological inhibitors or by transient-transfection approaches showed that inhibition of ERK1/ERK2 activity increased TGF-beta1-mediated cell adhesion slightly, but not the basal cell adhesion significantly, and that c-Src family kinase activity and decrease in Ras/ERKs cascade activity were required for the TGF-beta1 effects. Altogether, the present study indicates that TGF-beta1 treatment causes anchorage-independent gastric carcinoma cells to adhere by an increase in integrin alpha3 level and a c-Src family kinase activity-dependent decrease in Ras/ERKs cascade activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720123      PMCID: PMC1224061          DOI: 10.1042/BJ20031408

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Induction of anchorage-independent growth by transforming growth factor-beta linked to anchorage-independent expression of cyclin D1.

Authors:  X Zhu; E Scharf; R K Assoian
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

2.  Integrins regulate the linkage between upstream and downstream events in G protein-coupled receptor signaling to mitogen-activated protein kinase.

Authors:  S M Short; J L Boyer; R L Juliano
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

Review 3.  Ligand binding to integrins.

Authors:  E F Plow; T A Haas; L Zhang; J Loftus; J W Smith
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

Review 4.  Signal transduction by the TGF-beta superfamily.

Authors:  Liliana Attisano; Jeffrey L Wrana
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

5.  Integrin regulation of growth factor receptors.

Authors:  Kenneth M Yamada; Sharona Even-Ram
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

6.  SRC catalytic but not scaffolding function is needed for integrin-regulated tyrosine phosphorylation, cell migration, and cell spreading.

Authors:  Leslie A Cary; Richard A Klinghoffer; Christoph Sachsenmaier; Jonathan A Cooper
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 7.  v-Src's hold over actin and cell adhesions.

Authors:  Margaret C Frame; Valerie J Fincham; Neil O Carragher; John A Wyke
Journal:  Nat Rev Mol Cell Biol       Date:  2002-04       Impact factor: 94.444

8.  Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts.

Authors:  A Rodríguez-Barbero; J Obreo; L Yuste; J C Montero; A Rodríguez-Peña; A Pandiella; C Bernabéu; J M López-Novoa
Journal:  FEBS Lett       Date:  2002-02-27       Impact factor: 4.124

9.  Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Authors:  Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Silvia Colucci; Oronzo Schiraldi; Salvatore Antonaci
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1.

Authors:  Jong-Tak Kim; Choun-Ki Joo
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  10 in total

1.  Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer.

Authors:  Qingying Zhang; Min Zhu; Wenxiang Cheng; Rui Xing; Wenmei Li; Min Zhao; Liyan Xu; Enmin Li; Guangbin Luo; Youyong Lu
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-30       Impact factor: 4.553

2.  Src is a major signaling component for CTGF induction by TGF-beta1 in osteoblasts.

Authors:  X Zhang; J A Arnott; S Rehman; W G Delong; A Sanjay; F F Safadi; S N Popoff
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

3.  The signaling network of transforming growth factor beta1, protein kinase Cdelta, and integrin underlies the spreading and invasiveness of gastric carcinoma cells.

Authors:  Mi-Sook Lee; Tae Young Kim; Yong-Bae Kim; Sung-Yul Lee; Seong-Gyu Ko; Hyun-Soon Jong; Tae-You Kim; Yung-Jue Bang; Jung Weon Lee
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

4.  Application of a novel method of double APAAP staining with subsequent quantitative image analysis to the examination of integrin expression in undifferentiated-type gastric carcinomas.

Authors:  Natalia Yanchenko; Hiroyuki Sugihara; Takanori Hattori
Journal:  J Histochem Cytochem       Date:  2009-08-17       Impact factor: 2.479

5.  Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region.

Authors:  Kouji Katabami; Hiromi Mizuno; Rikio Sano; Yuta Saito; Masaharu Ogura; Saotomo Itoh; Tsutomu Tsuji
Journal:  Clin Exp Metastasis       Date:  2006-02-11       Impact factor: 5.150

6.  Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts.

Authors:  J A Arnott; X Zhang; A Sanjay; T A Owen; S L Smock; S Rehman; W G DeLong; F F Safadi; S N Popoff
Journal:  Bone       Date:  2008-01-26       Impact factor: 4.398

7.  Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors.

Authors:  Glenn A Driver; Robin B Veale
Journal:  Cancer Cell Int       Date:  2006-04-27       Impact factor: 5.722

8.  Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.

Authors:  Yun-Mi Goh; Senthilkumar Cinghu; Eileen Tan Hwee Hong; You-Soub Lee; Jang-Hyun Kim; Ju-Won Jang; Ying-Hui Li; Xin-Zi Chi; Kyeong-Sook Lee; Heejun Wee; Yoshiaki Ito; Byung-Chul Oh; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

9.  AFAP1 Is a Novel Downstream Mediator of TGF-β1 for CCN2 Induction in Osteoblasts.

Authors:  Youngjin Cho; Rachel Silverstein; Max T Geisinger; Stephen Martinkovich; Holly Corkill; Jess M Cunnick; Sonia L Planey; John A Arnott
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

Review 10.  Novel strategies for the treatment of chondrosarcomas: targeting integrins.

Authors:  Jui-Chieh Chen; Yi-Chin Fong; Chih-Hsin Tang
Journal:  Biomed Res Int       Date:  2013-12-30       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.